Related Experiment Videos

Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality

Benjamin Williams1, Madhav Menon, Daniel Satran

  • 1Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota 55407, USA.

Insights

Patients with severe coronary artery disease (CAD) not amenable to revascularization face higher mortality. This study found 28.8% of patients had significant CAD without complete revascularization, experiencing worse outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Severe coronary artery disease (CAD) poses a significant challenge, particularly when revascularization is not an option.
  • Optimal medical therapy may not suffice for all patients with severe CAD and persistent angina.
  • Contemporary data on the prevalence and outcomes of such patients are limited.

Purpose of the Study:

  • To determine the current prevalence of coronary artery disease (CAD) not amenable to revascularization.
  • To assess the 3-year all-cause mortality in patients with CAD unsuitable for revascularization.
  • To compare outcomes between completely and incompletely revascularized CAD patients.

Main Methods:

  • Review of clinical and angiographic data for 493 patients undergoing coronary angiography.
  • Categorization of patients into six groups based on coronary artery disease severity and revascularization status.
  • Determination of 3-year all-cause mortality across all patient groups.

Main Results:

  • 14.8% had normal coronaries, 19.5% had <70% CAD, 36.9% had >70% CAD with complete revascularization, 12.8% had >70% CAD with partial revascularization, 9.3% had >70% CAD treated medically, and 6.7% had >70% CAD with no revascularization option.
  • Three-year mortality rates were 2.7%, 6.3%, 8.2%, 12.7%, 17.4%, and 15.2% for the respective groups.
  • Patients with incomplete revascularization (n=142) had significantly higher 3-year mortality (14.8%) compared to completely revascularized patients (n=351, 6.6%; P=0.004).

Conclusions:

  • 28.8% of patients undergoing coronary angiography had significant CAD and did not achieve complete revascularization.
  • This subgroup included partially revascularized, medically treated, and "no-option" patients.
  • Incomplete revascularization in CAD patients is associated with significantly higher 3-year mortality.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...